MedPath

Comparison of optic nerve perfusion after pan retinal photocoagulation (PRP) versus anti vascular endothelial growth factor (antiVEGF) injection for treatment of high risk proliferative diabetic retinopathy(PDR)

Not Applicable
Conditions
Eye Diseases
Paediatrics
Registration Number
PACTR202206535473146
Lead Sponsor
Ain shams university hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
All
Target Recruitment
50
Inclusion Criteria

? Naive high risk PDR (neovascularization on disc (NVD) more than 1/3 disc area or any NVD with vitreous hemorrhage)
? clear media

Exclusion Criteria

? patients with media opacity
? other retinal and optic nerve diseases rather than diabetic retinopathy
? anti VEGF or steroid intravitreal injection
? previous PRP
? tractional retinal detachment
? glaucoma or any form of optic neuropathy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.